Scrip Regulatory Affairs
US IOM analysis finds little evidence of vaccine harm, debunks autism link
30 August 2011
Donna Young
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA action on drug shortages yields results, agency improves user fee goals
- US legislation seeks to give generics labelling change abilities
- US FDA equalises pre- and post-approval safety activities for drugs, reveals report
- Industry baulks at Indian ministry's call to ?pay clinical trial compensation or go?
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
